Chronic oral ascorbic acid therapy worsens skeletal muscle metabolism in patients with chronic heart failure

Nightingale, Angus K, Crilley, Jenifer G, Pegge, Nicholas C, Boehm, Ernie A, Mumford, Catherine, Taylor, Doris J, Styles, Peter, Clarke, Kieran and Frenneaux, Michael P (2007) Chronic oral ascorbic acid therapy worsens skeletal muscle metabolism in patients with chronic heart failure. European Journal of Heart Failure, 9 (3). pp. 287-291. ISSN 1388-9842

Full text not available from this repository.

Abstract

Chronic heart failure (CHF) is associated with abnormalities of skeletal muscle metabolism. This may be due to impaired oxygen delivery as a result of endothelial dysfunction.

Item Type:	Article
Uncontrolled Keywords:	adenosine triphosphate,aged,ascorbic acid,chronic disease,double-blind method,endothelium, vascular,female,great britain,heart failure,humans,magnetic resonance spectroscopy,male,middle aged,muscle, skeletal,phosphocreatine
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health
Depositing User:	Pure Connector
Date Deposited:	17 Mar 2015 12:22
Last Modified:	23 Apr 2023 01:03
URI:	https://ueaeprints.uea.ac.uk/id/eprint/52772
DOI:	10.1016/j.ejheart.2006.06.006

Actions (login required)

View Item